Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells
- PMID: 267156
Item in Clipboard
Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells
J Med.
1977.
Abstract
Circulation time of isotope labeled ascites tumor cells was measured after intravenous injection into mice. Circulation time was approximately doubled by pretreatment with the platelet aggregation inhibitor compound bencyclan.
Similar articles
-
[The effect of bencyclan on shear induced platelet aggregation (author's transl)].Arzneimittelforschung. 1975 Jul;25(7):1064-7. Arzneimittelforschung. 1975. PMID: 1174412 German.
-
[Inhibitory activity of bencyclan on platelet aggregation in vitro and in vivo (author's transl)].Arzneimittelforschung. 1975;25(12):1938-44. Arzneimittelforschung. 1975. PMID: 1243666 German.
-
Study of platelet aggregation in vivo i. Effect of bencyclan.J Med. 1976;7(6):439-47. J Med. 1976. PMID: 827596
-
[Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].Laryngol Rhinol Otol (Stuttg). 1983 Dec;62(12):578-85. Laryngol Rhinol Otol (Stuttg). 1983. PMID: 6369051 Review. German.
-
[Cancer metastasis and platelet aggregation].Tanpakushitsu Kakusan Koso. 1990 Nov;35(15):2818-24. Tanpakushitsu Kakusan Koso. 1990. PMID: 2259729 Review. Japanese. No abstract available.
Cited by
-
Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine.Clin Exp Metastasis. 1984 Jan-Mar;2(1):61-72. doi: 10.1007/BF00132307. Clin Exp Metastasis. 1984. PMID: 6543691